Effect of Atelocollagen Injection in Patients With Calcific Tendinitis

NCT06040112 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2024-04-12

No results posted yet for this study

Summary

Assess the clinical outcomes using atelocollagen injection in patients with calcific tendinitis.

Conditions

  • Calcific Tendinitis of Shoulder
  • Atelocollagen

Interventions

DEVICE

Atelocollagen

Tendoregen (Atelocollagen) injection

Sponsors & Collaborators

  • Hyungsuk Kim

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-06
Primary Completion
2024-12-31
Completion
2025-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06040112 on ClinicalTrials.gov